Connection
Ernesto Sparrelid to Sweden
This is a "connection" page, showing publications Ernesto Sparrelid has written about Sweden.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.754 |
|
|
|
-
Holmberg M, Radkiewicz C, Strömberg C, Öman M, Ghorbani P, Löhr JM, Sparrelid E. Outcome after surgery for invasive intraductal papillary mucinous neoplasia compared to conventional pancreatic ductal adenocarcinoma - A Swedish nationwide register-based study. Pancreatology. 2023 Jan; 23(1):90-97.
Score: 0.196
-
Swartling L, Allard A, Törlen J, Ljungman P, Mattsson J, Sparrelid E. Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2015 Dec; 17(6):785-94.
Score: 0.119
-
Sterner J, Andersson M, Olofsson A, Jansson H, Strömberg C, D'Souza M, Sturesson C, Sparrelid E, Gerling M, Gilg S, Engstrand J. Impact of post-hepatectomy liver failure on recurrence following major hepatectomy for colorectal cancer liver metastases. HPB (Oxford). 2025 Oct; 27(10):1309-1317.
Score: 0.059
-
Dall'Olio T, Perri G, Reese T, Sparrelid E, Gilg S. Implementation of a robotic hepato-pancreato-biliary surgery program: a swedish referral center's experience. J Robot Surg. 2025 Mar 06; 19(1):101.
Score: 0.057
-
Oba A, Tanaka K, Inoue Y, Valente R, Rangelova E, Arnelo U, Ono Y, Sato T, Torphy RJ, Ito H, Löhr M, Takahashi Y, Schulick RD, Saiura A, Sparrelid E, Del Chiaro M. Pancreatectomies with vein resection: Two large institutions' experience of East and West. Pancreatology. 2025 Mar; 25(2):250-257.
Score: 0.057
-
Radkiewicz C, Ludvigsson JF, Sparrelid E, Emilsson L. Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study. Eur J Cancer. 2025 Jan; 214:115140.
Score: 0.056
-
Villard C, Widman L, Sparrelid E, Bergquist A, Hagström H. The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Scand J Gastroenterol. 2024 11; 59(11):1249-1251.
Score: 0.056
-
Sanjeevi S, Sparrelid E, Gilg S, Jonas E, Isaksson B. High incidence of biliary stricture after associating liver partition and portal vein ligation for staged hepatectomy. ANZ J Surg. 2018 Jul-Aug; 88(7-8):760-764.
Score: 0.035
-
Gilg S, Sparrelid E, Isaksson B, Lundell L, Nowak G, Strömberg C. Mortality-related risk factors and long-term survival after 4460 liver resections in Sweden-a population-based study. Langenbecks Arch Surg. 2017 Feb; 402(1):105-113.
Score: 0.032
-
Björnsson B, Sparrelid E, Røsok B, Pomianowska E, Hasselgren K, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results. Eur J Surg Oncol. 2016 Apr; 42(4):531-7.
Score: 0.030
-
Røsok BI, Björnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery. 2016 May; 159(5):1279-86.
Score: 0.030
-
Spelt L, Sparrelid E, Isaksson B, Andersson RG, Sturesson C. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. HPB (Oxford). 2015 Jun; 17(6):529-35.
Score: 0.029
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|